Tumor CD20 Loss and Poor Outcome in Relapsed/Refractory (R/R) Diffuse Large B- Cell Lymphoma (DLBCL)

被引：0
|
作者：
Alchidiac, Jessy [1 ,2 ]
Hueso, Thomas [1 ]
Massard, Christophe [1 ]
Ribrag, Vincent [1 ]
Michot, Jean-Marie [1 ]
机构：
[1] Inst Gustave Roussy, Paris, France
[2] Lebanese Univ, Beirut, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
ABCL; relapsed/refractory non-Hodgkin Lymphoma; CD20; loss; CD20 weak expression; biopsy at relapse;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-119
引用
收藏
页码：S457 / S457
页数：1
相关论文
共 50 条
  • [41] Independent Predictive Value of PET-CT Pre Transplant in Relapsed and Refractory Patients with CD20 Diffuse Large B-Cell Lymphoma (DLBCL) Included in the CORAL Study
    Trneny, Marek
    Bosly, Andre
    Bouabdallah, Krimo
    Ma, David
    Shpilberg, Ofer
    Montoto, Silvia
    Sebban, Catherine
    Hagberg, Hans
    Moskowitz, Craig H.
    Schmitz, Norbert
    Gisselbrecht, Christian
    BLOOD, 2009, 114 (22) : 363 - 363
  • [42] THE CURE MYTH: EXPERIENCE FROM RECENT HEALTH TECHNOLOGY ASSESSMENT (HTA) SUBMISSIONS IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
    Mohseninejad, L.
    Hardy, A.
    Westley, T.
    Kongnakorn, T.
    VALUE IN HEALTH, 2022, 25 (01) : S8 - S8
  • [43] A Phase Ib Open-Label Study of MRG001 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
    Zhu, Jun
    Song, Yuqin
    Guo, Ye
    Zhou, Keshu
    Li, Wenyu
    Yang, Yu
    Cai, Qingqing
    Wang, Zhao
    Yang, Haiyan
    BLOOD, 2023, 142
  • [44] Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Ayyappan, Sabarish
    Kim, Won Seog
    Kim, Tae Min
    Walewski, Jan
    Cho, Seok-Goo
    Jarque, Isidro
    Iskierka-Jazdzewska, Elzbieta
    Poon, Michelle
    Oh, Sung Yong
    Lim, Francesca Lorraine Wei Inng
    Carpio, Cecilia
    Tan, Tran-Der
    Gutierrez, Antonio
    Zhang, Huilai
    Cao, Junning
    Zhang, Mingzhi
    Tessoulin, Benoit
    Li, Jingjin
    Ufkin, Melanie
    Shariff, Saleem
    Chi, Lei
    Chaudhry, Aafia
    Mohamed, Hesham
    Ambati, Srikanth
    Prince, H. Miles
    BLOOD, 2023, 142
  • [45] Long-term survival projections of loncastuximab tesirine-treated patients in relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Hamadani, Mehdi
    Graham, Christopher N.
    Liao, Laura
    Zhang, Katherine H.
    Strat, Hannah
    Ungar, David
    Ai, Weiyun Z.
    Chen, Lei
    Carlo-Stella, Carmelo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients
    Sar, Aylin
    Perizzolo, Marco
    Stewart, Doug
    Mansoor, Adnan
    DiFrancesco, Lisa M.
    Demetrick, Douglas J.
    LEUKEMIA RESEARCH, 2009, 33 (06) : 792 - 797
  • [47] Relapsed / Refractory International Prognostic Index (R/R-IPI): An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma
    Maurer, Matthew J.
    Jakobsen, Lasse H.
    Mwangi, Raphael
    Schmitz, Norbert
    Farooq, Umar
    Flowers, Cristopher R.
    de Nully Brown, Peter
    Thompson, Carrie A.
    Frederiksen, Henrik
    Cunningham, David
    Jorgensen, Judit
    Poeschel, Viola
    Nowakowski, Grzegorz
    Seymour, John F.
    Merli, Francesco
    Haioun, Corinne
    Ghesquieres, Herve
    Ziepert, Marita
    Tilly, Herve
    Salles, Gilles
    Shi, Qian
    El-Galaly, Tarec C.
    Habermann, Thomas M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) : 599 - 605
  • [48] Phase 1b/3 study of avelumab-based combination regimens in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
    Chen, Robert W.
    Ansel, Stephen Maxted
    Zinzani, Pier Luigi
    Vacirca, Jeffrey L.
    Lopez-Guillermo, Armando
    Hutchings, Martin
    Jurczak, Wojciech
    Hess, Georg
    Le Gouill, Steven
    Offner, Fritz
    Santoro, Armando
    Salles, Gilles A.
    Stypinski, Darla
    Laird, Douglas
    Pavlov, Dmitri
    Andreola, Giovanna
    Fly, Kolette D.
    Woolfson, Adrian
    Collins, Graham P.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Results from a phase 1b study of blinatumomab-pembrolizumab combination in adults with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
    Giri, Pratyush
    Patil, Sushrut
    Ratnasingam, Sumita
    Prince, H. Miles
    Milliken, Samuel
    Meijide, Javier Briones
    Coyle, Luke
    Van der Poel, Marjolein
    Mulroney, Carolyn M.
    Farooqui, Mohammed Z. H.
    Wong, Hansen
    Desai, Rajendra
    Zugmaier, Gerhard
    Mergen, Noemi
    Cannell, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma
    Michot, Jean-Marie
    Buet-Elfassy, Alice
    Annereau, Maxime
    Lazarovici, Julien
    Danu, Alina
    Sarkozy, Clementine
    Chahine, Claude
    Bigenwald, Camille
    Bosq, Jacques
    Rossignol, Julien
    Romano-Martin, Patricia
    Baldini, Capucine
    Ghez, David
    Dartigues, Peggy
    Massard, Christophe
    Ribrag, Vincent
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 710 - 718
12345